4//SEC Filing
May Sara R. 4
Accession 0000950142-25-002017
CIK 0001997296other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:15 PM ET
Size
7.3 KB
Accession
0000950142-25-002017
Insider Transaction Report
Form 4
May Sara R.
Director
Transactions
- Award
Stock Option (right to buy)
2025-07-22+25,000→ 25,000 totalExercise: $3.08Exp: 2030-07-22→ Common Shares (25,000 underlying)
Holdings
- 15,000
Stock Option (right to buy)
Exercise: $2.75Exp: 2029-12-17→ Common Shares (15,000 underlying)
Footnotes (3)
- [F1]Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
- [F2]The board of directors of Medicus Pharma Ltd. (the ?Board?) approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest quarterly in four equal installments over one year from the initial grant date of December 17, 2024. All these options are now vested.
- [F3]The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year.
Documents
Issuer
Medicus Pharma Ltd.
CIK 0001997296
Entity typeother
Related Parties
1- filerCIK 0002048946
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:15 PM ET
- Size
- 7.3 KB